Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that Jean-Pierre Sommadossi, PhD, Chief Executive Officer and Founder of Atea, together with other members of the Atea management team, will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026 at 12:20 p.m. EDT in New York, NY.
Covered in this story
What has happened since
- Atea Pharmaceuticals Inc is down 28.7% since this was published, 44 days ago.
- Morgan Stanley is down 14.9% since this was published, 44 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $AVIR yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Atea Pharmaceuticals Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.